Arrow Greentech Limited Approves Grant of 61,000 Options Under ESOP Scheme

Arrow Greentech Limited Approves Grant of 61,000 Options Under ESOP Scheme

Arrow Greentech Limited Approves Grant of 61,000 Options Under ESOP Scheme​

Arrow Greentech Limited has announced that its Nomination and Remuneration Committee (NRC) has approved the grant of 61,000 Employee Stock Options (Options) to eligible employees. These options fall under the company's internal framework, the Arrow Greentech ESOP Scheme - 2024.

The grant is designed to provide incentives to identified employees, covering a total of 61,000 stock options. These options are exercisable into an equal number of equity shares, each having a face value of Rs. 10/- (Rupees Ten) fully paid up in the Company.

According to the details provided regarding the ESOP grant, the key terms and financial specifications are as follows:

ParameterDetail
Total Options Granted61,000 Employee Stock Options
Total Shares Covered61,000 Equity Shares
Exercise Price Per OptionRs. 359/-
Vesting PeriodOptions must have a minimum 1 Year Vesting period from the date of Grant and vest according to the specified Grant Letter schedule.
Exercise TimelineVested Options shall be excisable within a period of three years from the date of vesting.

The company confirmed that the Options granted are subject to the structure of the Arrow Greentech ESOP Scheme - 2024. The exercise of these options, which are priced at Rs. 359/- per option, forms part of the company's employee benefits plan.

ARROWGREEN Stock Price Movement​

Today, Arrow Greentech Limited shares slipped by 0.86% to settle at ₹477.25. The equity traded on 23,271 shares, marking a downward movement within an intraday range of ₹470.00 to ₹497.80.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top